Evidence map›Paper›PMID 39688685›Full record

ArticleBioprocess and biosystems engineering2025

A novel bioactive and functional exopolysaccharide from the cyanobacterial strain Arthrospira maxima cultivated under salinity stress.

Amel Harbaoui, Nadia Khelifi, Neyssene Aissaoui, Murielle Muzard, Agathe Martinez, Issam Smaali

Abstract read
PubMed Publisher
In one paragraph

Article in Bioprocess and biosystems engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Amel HarbaouiDepartment of Chemical and Biological Engineering, Laboratory of Protein Engineering and Bioactive Molecules (LR11ES24), INSAT, University of Carthage, BP 676, 1080, Tunis Cedex, Tunisia.
Nadia KhelifiDepartment of Chemical and Biological Engineering, Laboratory of Protein Engineering and Bioactive Molecules (LR11ES24), INSAT, University of Carthage, BP 676, 1080, Tunis Cedex, Tunisia.
Neyssene AissaouiDepartment of Chemical and Biological Engineering, Laboratory of Protein Engineering and Bioactive Molecules (LR11ES24), INSAT, University of Carthage, BP 676, 1080, Tunis Cedex, Tunisia.
Murielle MuzardUniversité de Reims Champagne-Ardenne, CNRS, ICMR, Reims, France.
Agathe MartinezUniversité de Reims Champagne-Ardenne, CNRS, ICMR, Reims, France.
Issam SmaaliDepartment of Chemical and Biological Engineering, Laboratory of Protein Engineering and Bioactive Molecules (LR11ES24), INSAT, University of Carthage, BP 676, 1080, Tunis Cedex, Tunisia. Issam.smaali@insat.rnu.tn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyanobacterial exopolysaccharides (EPS) remain released by cyanobacteria in the surrounding environment with the main purpose of protection against harmful environmental conditions. Recently, they have received significant attention due to their unique structural characteristics, functional properties, and potential applications across various fields. The current study describes the evaluation of EPS production under salinity stress from Arthrospira maxima. The application of high salinity up to 40 g/L enhanced EPS production, which was collected and purified by alcohol precipitation followed by membrane dialysis and lyophilization. A yield of 60 mg/L was obtained. The Size exclusion chromatography gave for the purified EPS an apparent molecular weight of 2.1 × 10

Indexed as

Anti-Bacterial AgentsCyanobacteriaPolysaccharides, BacterialSalt StressSpirulinaAntioxidantsAnti-Bacterial AgentsAntioxidantsPolysaccharides, BacterialAntimicrobial activityAntioxidant activityArthrospira maximaEmulsifying activityEPSSalinity stress

Identifiers

PMID39688685

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.